Call for Papers now open! We welcome the submission of manuscripts focused on the application of cardiac imaging to the study of health disparities, including investigations of understudied diseases, access to care, and other diverse topics. ahajournals.org/journal/circim… #AHAJournals

Utilization of Cardiovascular Magnetic Resonance Imaging for Resumption of Athletic Activities Following COVID-19 Infection: An Expert Consensus Document... Michael Jerosch-Herold Pamela Woodard, MD Frederick L Ruberg Chetan Shenoy Allison G. Hays, MD #AHAJournals
ahajrnls.org/3QVT9qm

.American College of Cardiology's 🆕 Expert Consensus Decision Pathway provides practical and timely guidance on the diagnosis and management of cardiac #amyloidosis , with an emphasis on comprehensive multidisciplinary care.

Learn more: bit.ly/3HrCat8

#JACC #CardioOnc #CardioTwitter

Registration is NOW OPEN for the 2023 Massachusetts ACC Annual Mtg - join us Waltham Woods on April 1! mcacc.wildapricot.org/event-5123981 Colleen Harrington MD, FACC, FASE James Januzzi Jr MD Malissa Wood Omar K. Siddiqi, MD, FACC Michelle L. Hadley, D.O., FACC Frederick L Ruberg Saurabh S Dani, MD, MSc Ron Blankstein Anne-Marie Anagnostopoulos, MD Meghan York MD Kim Guibone DNP, APRN, FACC

Rigorous #FOURIER event adjudication explained - misguided & uninformed attacks refuted!
timi.org/bmjopenrespons…

CardioNerds episode released!

🎤252. #CardioOncology : Cardiac #Amyloidosis with Omar K. Siddiqi, MD, FACC

Feat: FIT lead Dan Davies, MD, series co-chair Dinu V. Balanescu, M.D..

🙏Audio editing by Chelsea Amo Tweneboah, MD

👇Peals, notes, graphics👇
cardionerds.com/252-cardio-onc…

CircImaging Frederick L Ruberg Chetan Shenoy Allison G. Hays, MD Identification of TTR cardiac amyloidosis in previously diagnosed HCM utilizing cardiac scintigraphy in consecutive patients. 3% of patients >60 yrs had TTR-CM including 8% of previously diagnosed nonobstructive HCM patients. @LaheyCardiology Martin Maron, MD

Happy Holidays! I'm happy to post this opportunity for clinical and research training in the 23-24 AY in #amyloidosis at Boston Medical Center and Boston U Chobanian & Avedisian School of Medicine. Please apply by January 13, 2023 if interested and DM/email with questions. BU Amyloidosis Center BMC|BU Cardiology Fellows

Congrats Emelia J. Benjamin on leading this important effort! BMC|BU Cardiology Fellows Boston U Chobanian & Avedisian School of Medicine Boston Medical Center NIH NHLBI
Transforming Atrial Fibrillation Research to Integrate Social Determinants of Health ja.ma/3hgWhQv via JAMA Cardiology part of JAMA Network

Don't miss the #AmyloidosisForum fifth session: exploring Cardiac MRI as an Imaging-Based Biomarker for AL & ATTR #amyloidosis :

Huge congratulations to my dear friend and colleague, wonderful mentor, inspirational leader and researcher ⁦Sharmila Dorbala on her #AHA2022 Clinical Council #WIC Mentoring Award! Thank you for mentoring so many of us! ⁦Renée Bullock-Palmer MD FACC FAHA FASNC FASE FSCCT⁩ ⁦Niti R. Aggarwal, MD, FSCMR, FASNC, FACC⁩ ⁦Sarah Cuddy⁩

So proud of Boston U Chobanian & Avedisian School of Medicine student Avni Madhani and her poster today at AHA 22 on hereditary cardiac amyloidosis. Her first scientific meeting! AHA Science #AHA22 Boston Medical Center BU Amyloidosis Center

A strain-based classification reflects the pathophysiological spectrum of LBBB-induced remodeling and predicts the extent of volumetric CRT response Department of Cardiovascular Sciences - KU Leuven Jürgen Duchenne Chetan Shenoy Allison G. Hays, MD #AHAJournals ahajrnls.org/3FL2b65

Our very own Dr. Ruberg, Dr. Siddiqi, Dr. Lau & Dr. Kaku will be presenting at an Amyloidosis webinar one week from today on October 28! Register to learn more about updates in ATTR Cardiac and Neurological Amyloidosis Frederick L Ruberg Omar K. Siddiqi, MD, FACC pathlms.com/amyloidosis/we…

Proud of my friend and colleague Omar K. Siddiqi, MD, FACC interviewed by Darae Ko, MD, MSc, FAHA in a career conversation on medical education. I cannot imagine a more dedicated and invested cardiology PD. We at BMC|BU Cardiology Fellows are so lucky to have him! American College of Cardiology Massachusetts ACC Boston Medical Center
acc.org/membership/sec…

Reverse remodeling after TAVR differs between lone AS and AS-ATTR cardiac amyloidosis despite both groups experiencing symptomatic improvement. ahajournals.org/doi/10.1161/CI… Christian Nitsche Kardiologie MedUni Wien Forschung Georg Goliasch Allison G. Hays, MD Chetan Shenoy #AHAJournals

Save the date for our next #CircImgJC : May 5, 19:00 UTC (3PM EDT). We'll be joined by Erin D. Michos, M.D. and co-authors to discuss their recently published paper, with Allison G. Hays, MD and Chetan Shenoy moderating. Paper: ahajournals.org/doi/10.1161/CI…

The use of zero CACS as a screening tool to avoid MPI in intermediate-high risk patients with suspected ischemic symptoms could lead to missing a diagnosis of #cvCMD in 4 in 10. #LimitsofPowerofZero Krishna Patel Chetan Shenoy Allison G. Hays, MD #AHAJournals ahajournals.org/doi/abs/10.116…

Great to see screening and treatment of Cardiac amyloidosis prominently included in the HFSA ACC AHA Heart failure guidelines Sharmila Dorbala Frederick L Ruberg Martha Grogan MD ASNC Society American College of Cardiology NJ Chapter of ACC

Spread the word: mathew.maurer Ronald Witteles Mazen Hanna Frederick L Ruberg Brett Sperry, MD Vincent Rajkumar Michelle Kittleson MD PhD David Fermin, MD Omar AbouEzzeddine MDCM, MS (He/Him/His) Melissa Lyle Julie Lorraine Rosenthal Mayo Amyloid Vaishali Sanchorawala Ahmad Masri Michael Chetrit Dr. Jeffrey Zonder